Navigation Links
William Cork Joins Fenwal as Chief Technology Officer
Date:11/10/2009

LAKE ZURICH, Ill., Nov. 10 /PRNewswire/ -- Fenwal Inc., a global medical technology company focused on improving blood collection, separation, safety and availability, announced today William H. Cork has joined the company as senior vice president and chief technology officer. Mr. Cork, 50, will lead Fenwal's research and development, regulatory and clinical affairs teams, reporting to Ron K. Labrum, Fenwal's president and chief executive officer.

Mr. Cork joins Fenwal from Northbrook, Illinois-based Nanosphere Inc. (Nasdaq: NSPH), where he was chief technology officer and vice president of research and development since 2001. Nanosphere focuses on molecular diagnostic testing.

Prior to this, Mr. Cork was vice president of research and development for Fenwal (then a division of Baxter International), where he led the development and global commercialization of platelet and cell-collection technologies, including Fenwal's Amicus and CS-3000 separator portfolios.

"Bill is a strong and experienced scientific leader, with deep knowledge of advanced molecular science, software development and transfusion medicine with clinical relationships worldwide," Labrum said. "His decade-long tenure with us in the 1990s was one of the most innovative and productive periods in Fenwal's recent history."

Mr. Cork holds more than 15 medical-technology patents and has another seven pending. He earned a bachelor's degree in electrical engineering from Northwestern University, where he also minored in biomedical engineering. Mr. Cork replaces Hiroshi Uchida as a member of Fenwal's executive team. Mr. Uchida transitioned last month to Fenwal's board of directors.

Fenwal Inc. is a global medical technology company focused on improving blood collection, separation, safety and availability for patient care. Fenwal became an independent company in 2007, but its roots go back to 1949 with the founding of Fenwal Laboratories. Fenwal developed the first flexible, disposable container for blood collection, eliminating complications associated with glass containers and allowing blood to be separated into therapeutic components. Today, the company's products and advanced collection and separation technologies are used throughout the world to help ensure a safe and available supply of lifesaving blood and blood products. Fenwal Inc. is based in Lake Zurich, Illinois. For more information, please visit www.fenwalinc.com.

SOURCE Fenwal Inc.


'/>"/>
SOURCE Fenwal Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Keryx Biopharmaceuticals to Present at William Blair & Company Small-Cap Growth Stock Conference
2. William R. Ringo Joins Hyperion Therapeutics, Inc. Board of Directors as Chairman
3. Velcura Therapeutics, Inc. Adds William Brinkerhoff to its Board of Directors
4. Dr. Derek Winstanly of Quintiles to Serve as 2009 ACRO Chair; Mr. William Sharbaugh of PPD to Be Chair-Elect
5. Letter to Shareholders From Imagenetix, Inc. President/CEO William Spencer
6. Autism Spectrum Therapies Co-Founder and Chief Clinical Officer Dr. William Frea Appointed to Board of Directors of Los Angeles Chapter of Autism Speaks
7. PAREXEL International to Present at William Blair Emerging Growth Stock Conference
8. Glamour Magazine Woman of the Year and MISSION Skincare Co-Founder, Serena Williams, Teams Up with CVS/pharmacy to Launch National Active Lifestyle Skincare Destinations
9. General Wesley Clark Joins Immtech as Consulting Strategic Advisor
10. Actress and New Mom Keri Russell Joins PKIDs to launch Silence the Sounds of Pertussis Campaign
11. Video: Actress and New Mom Keri Russell Joins PKIDs to Launch Silence the Sounds of Pertussis Campaign
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/10/2017)... , May 10, 2017 CSSi, the global ... the clinical research industry, is proud to announce the ... The new website features both enriched content and a ... and enhances the company,s already well-established position as the ... "After many months of hard work, we ...
(Date:5/9/2017)... WASHINGTON , May 9, 2017  Demonstrating ... the board of directors for the Pharmaceutical Research ... criteria for membership. Biopharmaceutical companies will now have ... in order to be eligible to join PhRMA. ... criteria, the board is sending a clear message ...
(Date:5/9/2017)... , May 9, 2017  Semler Scientific, Inc. ... technology solutions to improve the clinical effectiveness and ... for the first quarter ended March 31, 2017. ... enable our customers to identify when preventive care ... before events like heart attacks or strokes occur," ...
Breaking Medicine Technology:
(Date:5/26/2017)... ... May 26, 2017 , ... Amir Qureshi, MD is the first ... patient-centric spinal cord stimulation system. The Nuvectra™ Algovita SCS System has been FDA approved ... be the first in Arkansas to introduce the most powerful SCS system and the ...
(Date:5/26/2017)... ... May 26, 2017 , ... ... foods, is sharing bold recipes for Memorial Day entertaining that are sure to ... , “Boar’s Head fresh sliced meats and cheeses featured in these refreshingly balanced ...
(Date:5/26/2017)... MD (PRWEB) , ... May 26, 2017 , ... After ... anti-stress Antzy Top gadget will continue to be available at a discounted crowdfunding price ... deal with stress wherever they are, I also wanted to bring a fidget toy ...
(Date:5/26/2017)... ... 26, 2017 , ... Rob Lowe acts as host and helps educate and ... on hiking in American. Viewers can reconnect with America as it explores some of ... Many consumers have looked for an inventive new place for a family vacation, and ...
(Date:5/26/2017)... ... ... the Cross”: the personal journey of Bob Massey and his faith in the Lord. ... Margaret Massey. Bob Massey is small in stature but big in character. As ... for others is apparent in all of his life decisions. , “I’m in the ...
Breaking Medicine News(10 mins):